Advertisement

Topics

Acerus Announces Approval of NATESTO® in South Korea

07:00 EDT 14 Jun 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Acerus Pharmaceuticals Corporation (TSX:ASP) (Acerus or the Company”) announced today that Hyundai Pharm Co., Ltd. (Hyundai), Acerus’ licensee, reported that South Korea’s Ministry of Food and Drug Safety (MFDS) has approv...

Other Sources for this Article

Acerus Pharmaceuticals Corporation
Tricia Symmes, 416-509-2116
Chief Operating Officer
tsymmes@aceruspharma.com

NEXT ARTICLE

More From BioPortfolio on "Acerus Announces Approval of NATESTO® in South Korea"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...